Le Blanc K
Division of Clinical Immunology, Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.
Cytotherapy. 2003;5(6):485-9. doi: 10.1080/14653240310003611.
Mesenchymal stem cells (MSC) derived from adult BM or fetal liver form several mesenchymal tissues after appropriate stimulation. Reports indicate that MSC have unique immunologic properties, making them ideal for cellular therapy. MSC are not immunogenic, they do not stimulate alloreactivity, and they escape lysis by cytotoxic T-cells and natural killer (NK)-cells. Thus, MSC may be transplantable between HLA-mismatched individuals without the need for host immunosuppression. Furthermore, adult MSC appear to be immunosuppressive as they reduce alloreactivity and the formation of cytotoxic lymphocytes in vitro. In vivo, adult MSC prolong the time to rejection of mis-matched skin grafts in baboons. The immunosuppressive properties of first trimester fetal MSC are less pronounced, but inducible with IFNgamma. These findings imply a potential role for MSC, not only in the repair of damaged tissues, but also in the manipulation of immune responses.
源自成人骨髓或胎儿肝脏的间充质干细胞(MSC)在适当刺激后可形成多种间充质组织。报告表明,MSC具有独特的免疫特性,使其成为细胞治疗的理想选择。MSC没有免疫原性,不会刺激同种异体反应,并且能逃避细胞毒性T细胞和自然杀伤(NK)细胞的裂解。因此,MSC可在HLA不匹配的个体之间进行移植,而无需宿主免疫抑制。此外,成人MSC似乎具有免疫抑制作用,因为它们在体外可降低同种异体反应和细胞毒性淋巴细胞的形成。在体内,成人MSC可延长狒狒中不匹配皮肤移植的排斥时间。孕早期胎儿MSC的免疫抑制特性不太明显,但可被γ干扰素诱导。这些发现暗示了MSC不仅在受损组织修复中,而且在免疫反应调控中都具有潜在作用。